These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 32886158)
1. Dissociable dopaminergic and pavlovian influences in goal-trackers and sign-trackers on a model of compulsive checking in OCD. Eagle DM; Schepisi C; Chugh S; Desai S; Han SYS; Huang T; Lee JJ; Sobala C; Ye W; Milton AL; Robbins TW Psychopharmacology (Berl); 2020 Dec; 237(12):3569-3581. PubMed ID: 32886158 [TBL] [Abstract][Full Text] [Related]
2. The dopamine D2/D3 receptor agonist quinpirole increases checking-like behaviour in an operant observing response task with uncertain reinforcement: a novel possible model of OCD. Eagle DM; Noschang C; d'Angelo LS; Noble CA; Day JO; Dongelmans ML; Theobald DE; Mar AC; Urcelay GP; Morein-Zamir S; Robbins TW Behav Brain Res; 2014 May; 264(100):207-29. PubMed ID: 24406720 [TBL] [Abstract][Full Text] [Related]
3. Checking responses of goal- and sign-trackers are differentially affected by threat in a rodent analog of obsessive-compulsive disorder. Vousden GH; Paulcan S; Robbins TW; Eagle DM; Milton AL Learn Mem; 2020 May; 27(5):190-200. PubMed ID: 32295839 [TBL] [Abstract][Full Text] [Related]
4. Examining the role of dopamine D2 and D3 receptors in Pavlovian conditioned approach behaviors. Fraser KM; Haight JL; Gardner EL; Flagel SB Behav Brain Res; 2016 May; 305():87-99. PubMed ID: 26909847 [TBL] [Abstract][Full Text] [Related]
5. Kappa-opioid receptor stimulation quickens pathogenesis of compulsive checking in the quinpirole sensitization model of obsessive-compulsive disorder (OCD). Perreault ML; Seeman P; Szechtman H Behav Neurosci; 2007 Oct; 121(5):976-91. PubMed ID: 17907829 [TBL] [Abstract][Full Text] [Related]
6. Lesions of the ventral hippocampus attenuate the acquisition but not expression of sign-tracking behavior in rats. Fitzpatrick CJ; Creeden JF; Perrine SA; Morrow JD Hippocampus; 2016 Nov; 26(11):1424-1434. PubMed ID: 27438780 [TBL] [Abstract][Full Text] [Related]
7. Individual differences in the propensity to approach signals vs goals promote different adaptations in the dopamine system of rats. Flagel SB; Watson SJ; Robinson TE; Akil H Psychopharmacology (Berl); 2007 Apr; 191(3):599-607. PubMed ID: 16972103 [TBL] [Abstract][Full Text] [Related]
8. Effects of hypophysectomy on compulsive checking and cortical dendrites in an animal model of obsessive-compulsive disorder. Dvorkin A; Culver KE; Waxman D; Szechtman H; Kolb B Behav Pharmacol; 2008 Jul; 19(4):271-83. PubMed ID: 18622174 [TBL] [Abstract][Full Text] [Related]
9. Contrafreeloading in Rats Is Adaptive and Flexible: Support for an Animal Model of Compulsive Checking. Frederick MJ; Cocuzzo SE Evol Psychol; 2017; 15(4):1474704917735937. PubMed ID: 29073770 [TBL] [Abstract][Full Text] [Related]
10. Quinpirole and 8-OH-DPAT induce compulsive checking behavior in male rats by acting on different functional parts of an OCD neurocircuit. Alkhatib AH; Dvorkin-Gheva A; Szechtman H Behav Pharmacol; 2013 Feb; 24(1):65-73. PubMed ID: 23249525 [TBL] [Abstract][Full Text] [Related]
11. Separate mechanisms for development and performance of compulsive checking in the quinpirole sensitization rat model of obsessive-compulsive disorder (OCD). Tucci MC; Dvorkin-Gheva A; Sharma R; Taji L; Cheon P; Peel J; Kirk A; Szechtman H Psychopharmacology (Berl); 2014 Sep; 231(18):3707-18. PubMed ID: 24682503 [TBL] [Abstract][Full Text] [Related]
12. Changes in gut microbiota during development of compulsive checking and locomotor sensitization induced by chronic treatment with the dopamine agonist quinpirole. Jung TD; Jung PS; Raveendran L; Farbod Y; Dvorkin-Gheva A; Sakic B; Surette MG; Szechtman H Behav Pharmacol; 2018 Apr; 29(2 and 3-Spec Issue):211-224. PubMed ID: 29194070 [TBL] [Abstract][Full Text] [Related]
13. 5-HT2A/C receptors do not mediate the attenuation of compulsive checking by mCPP in the quinpirole sensitization rat model of obsessive-compulsive disorder (OCD). Tucci MC; Dvorkin-Gheva A; Johnson E; Wong M; Szechtman H Behav Brain Res; 2015 Feb; 279():211-7. PubMed ID: 25449840 [TBL] [Abstract][Full Text] [Related]
14. Development and temporal organization of compulsive checking induced by repeated injections of the dopamine agonist quinpirole in an animal model of obsessive-compulsive disorder. Dvorkin A; Perreault ML; Szechtman H Behav Brain Res; 2006 May; 169(2):303-11. PubMed ID: 16524632 [TBL] [Abstract][Full Text] [Related]
15. Effects of the serotonergic agonist mCPP on male rats in the quinpirole sensitization model of obsessive-compulsive disorder (OCD). Tucci MC; Dvorkin-Gheva A; Graham D; Amodeo S; Cheon P; Kirk A; Peel J; Taji L; Szechtman H Psychopharmacology (Berl); 2013 May; 227(2):277-85. PubMed ID: 23354534 [TBL] [Abstract][Full Text] [Related]
16. Social interaction modulates the intensity of compulsive checking in a rat model of obsessive-compulsive disorder (OCD). Dorfman A; Szechtman H; Eilam D Behav Brain Res; 2019 Feb; 359():156-164. PubMed ID: 30389609 [TBL] [Abstract][Full Text] [Related]
17. Role of dopamine systems in obsessive-compulsive disorder (OCD): implications from a novel psychostimulant-induced animal model. Szechtman H; Culver K; Eilam D Pol J Pharmacol; 1999; 51(1):55-61. PubMed ID: 10389145 [TBL] [Abstract][Full Text] [Related]
18. Computational modelling reveals contrasting effects on reinforcement learning and cognitive flexibility in stimulant use disorder and obsessive-compulsive disorder: remediating effects of dopaminergic D2/3 receptor agents. Kanen JW; Ersche KD; Fineberg NA; Robbins TW; Cardinal RN Psychopharmacology (Berl); 2019 Aug; 236(8):2337-2358. PubMed ID: 31324936 [TBL] [Abstract][Full Text] [Related]
19. The Effect of Orexin Receptor Antagonism on Quinpirole-Induced Compulsive-Like Checking Behavior in Rats. Abounoori M; Maddah MM; Akbari E; Houshmand G; Ardeshiri MR Neurotox Res; 2020 Jun; 38(1):18-26. PubMed ID: 32207079 [TBL] [Abstract][Full Text] [Related]
20. Dorsolateral neostriatum contribution to incentive salience: opioid or dopamine stimulation makes one reward cue more motivationally attractive than another. DiFeliceantonio AG; Berridge KC Eur J Neurosci; 2016 May; 43(9):1203-18. PubMed ID: 26924040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]